Announced Tue, 27 Oct, 2026 · 17:58 IST
No use of ₹82.72 crore warrant proceeds; CARE reports no deviation
RAYMOND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
CARE Ratings' first report for the quarter ended September 30, 2026 says Raymond received ₹82.72 crore upfront from warrants allotted on July 9, 2026 under an issue worth up to ₹330.88 crore. No money was used for acquisitions or general corporate purposes. Of the ₹82.72 crore, ₹80 crore is in fixed deposits at 7.25% and ₹2.72 crore in mutual funds at 2.75%. CARE found no deviation or delay; the acquisition deadline is January 9, 2028.
Likely market impact
Planned acquisitions remain pending and warrant conversion may dilute existing shareholders, though unspent funds are earning returns.